Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]

NCT02080689 is registered in ClinicalTrials.gov with GenomeDx Biosciences Corp as lead sponsor.

NCT NCT02080689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02080689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Lead sponsor
GenomeDx Biosciences Corp
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2014
Completion date
February 1, 2017
Enrollment
286 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer